What is Fara?
Fara, identified as the Friedreich's Ataxia Research Alliance, is a nonprofit organization dedicated to eradicating Friedreich's ataxia. The alliance channels its efforts into funding critical research initiatives, supporting the progression of clinical trials, and cultivating a unified global community for those affected by the disease. FARA actively provides grants to promising research projects and collaborates closely with the FA research ecosystem to expedite the development of novel therapeutic interventions. Furthermore, the organization champions advocacy programs and disseminates vital resources, aiming to empower individuals impacted by this rare neurological disorder. Their core mission revolves around accelerating scientific breakthroughs and enhancing the quality of life for all individuals living with Friedreich's ataxia.
How much funding has Fara raised?
Fara has raised a total of $227K across 2 funding rounds:
Debt
$150K
Debt
$77K
Debt (2020): $150K with participation from PPP
Debt (2021): $77K led by PPP
Key Investors in Fara
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Fara?
With its recent influx of substantial expansion capital, Fara is strategically positioned for significant advancement. The large-scale, late-stage funding suggests a focus on scaling operations, potentially expanding research programs, or broadening the reach of its advocacy and support services. This investment will likely fuel the next phase of the organization's mission to accelerate research and improve outcomes for individuals affected by Friedreich's ataxia. The company's commitment to fostering a global community and supporting clinical trials indicates a forward-looking strategy aimed at tangible progress in treatment and, ultimately, a cure.
See full Fara company page
